Neurosciences News

In patients with neuromyelitis optica spectrum disorder, transition from rituximab to inebilizumab was linked to suppression of attacks over a mean 19 months of treatment, according to research published in Frontiers in Neurology.

A 57-year-old woman was transferred to Lahey Hospital and Medical Center emergency department from a community hospital for an ophthalmology evaluation due to acute, painless vision loss in the left eye upon wakening that morning.

The FDA approved Ultomiris for the treatment of adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, according to a press release from Alexion.

Lumevoq demonstrated sustained efficacy and a positive safety profile at 4 years after a one-time injection of the gene therapy in patients with Leber hereditary optic neuropathy, according to a press release from GenSight Biologics.

WEST PALM BEACH, Fla. — Hispanic and Latino individuals with neuromyelitis optica spectrum disorder experienced improved outcomes with Uplizna compared with placebo, according to a poster from ACTRIMS 2024.

Health Canada has approved Uplizna as a monotherapy for adults with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 immunoglobulin G seropositive.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Andrew G. Lee, MD, discusses neuro-ophthalmic mimics of thyroid eye disease.

WAILEA, Hawaii — In this Healio video perspective from Hawaiian Eye 2024, Andrew G. Lee, MD, overviews some of the major indicators that a patient with ptosis need to be hospitalized.

WAILEA, Hawaii — The Advanced Research Projects Agency for Health has launched a program to restore vision through the transplantation of whole human eyes, according to a speaker here.